Binimetinib Impurities and its Related Products
Displaying
25 results of
Binimetinib Impurities
Binimetinib Impurities refer to the by-products or unwanted substances that may be present in binimetinib, a drug used in the treatment of certain types of cancer. These impurities can affect the safety and efficacy of the drug, and their levels must be controlled to ensure the quality of the medication. Impurities can originate from various sources, including the manufacturing process, storage conditions, and degradation of the drug over time. Testing and monitoring for binimetinib impurities are necessary to ensure patient safety and compliance with regulatory requirements.
CAT No.
: CS-ED-41457
Mol F.
: C2H8N2O2
Mol W.
:
92.1 g/mol
Cas No.
: 5627-11-2
Stock
: Enquire
CAT No.
: CS-O-44864
Mol F.
: C7H2F3NO4
Mol W.
:
221.09 g/mol
Cas No.
: 132920-93-5
Stock
: Enquire
CAT No.
: CS-O-44865
Mol F.
: C7H4F2N2O4
Mol W.
:
218.11 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-38532
Mol F.
: C15H11BrF2N4O2
Mol W.
:
397.17 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-54665
Mol F.
: C16H12BrF2N5O4
Mol W.
:
456.20 g/mol
Cas No.
: Not Available
Stock
: Enquire
BINIMETINIB IMPURITIES, IMPURITIES
Binimetinib
CAT No.
: CS-T-31712
Mol F.
: C17H15BrF2N4O3
Mol W.
:
441.2 g/mol
Cas No.
: 606143-89-9
Stock
: Enquire
CAT No.
: CS-O-38052
Mol F.
: C17H15BrF2N4O3
Mol W.
:
441.23 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-44869
Mol F.
: C23H13BrF2N4O4
Mol W.
:
527.27 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-38051
Mol F.
: C15H10BrF2N3O2
Mol W.
:
382.16 g/mol
Cas No.
: 1415564-99-6
Stock
: Enquire
CAT No.
: CS-O-38053
Mol F.
: C21H23BrF2N4O3
Mol W.
:
497.33 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-44870
Mol F.
: C15H8BrF2N3O2
Mol W.
:
380.14 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-34970
Mol F.
: C21H23BrF2N4O4
Mol W.
:
513.33 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-EO-03998
Mol F.
: C15H11F2N3O2
Mol W.
:
303.26 g/mol
Cas No.
: 2649854-87-3
Stock
: Enquire
CAT No.
: CS-SN-00137
Mol F.
: C17H16F2N4O3
Mol W.
:
362.33 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-EO-03999
Mol F.
: C19H18F2N4O3
Mol W.
:
388.37 g/mol
Cas No.
: 2649854-88-4
Stock
: Enquire
CAT No.
: CS-O-38050
Mol F.
: C15H11BrF2N4O
Mol W.
:
381.17 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-44866
Mol F.
: C30H20Br2F4N8O2
Mol W.
:
760.33 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-38054
Mol F.
: C23H17Br2F3N4O3
Mol W.
:
614.21 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-44871
Mol F.
: C17H14BrF2N3O2
Mol W.
:
410.21 g/mol
Cas No.
: 2509103-99-3
Stock
: Enquire
CAT No.
: CS-EO-03997
Mol F.
: C19H19BrF2N4O3
Mol W.
:
469.28 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-44868
Mol F.
: C32H24Br2F4N8O4
Mol W.
:
820.39 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-38055
Mol F.
: C16H12BrF2N3O2
Mol W.
:
396.19 g/mol
Cas No.
: 1415559-93-1
Stock
: Enquire
CAT No.
: CS-O-44867
Mol F.
: C17H16BrF2N5O3
Mol W.
:
456.24 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-O-38533
Mol F.
: C17H14BrF2N4O4-
Mol W.
:
456.22 g/mol
Cas No.
: Not Available
Stock
: Enquire
CAT No.
: CS-P-08734
Mol F.
: C16H13BrF2N4O3
Mol W.
:
427.21 g/mol
Cas No.
: Not Available
Stock
: Enquire
![5-(4-bromo-2-fluorophenylamino)-4-fluoro-N-hydroxy-1-methyl-1H-benzo[d]imidazole-6-carboxamide](https://structures.clearsynth.com/5--4-bromo-2-fluorophenylamino--4-fluoro-N-hydroxy-1-methyl-1H-benzo-d-imidazole-6-carboxamide.png "Binimetinib Impurities")
![5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-nitroso-1H-benzimidazole-6-carboxamide](https://structures.clearsynth.com/5---4-bromo-2-fluorophenyl-amino--4-fluoro-N--2-hydroxyethoxy--1-nitroso-1H-benzimidazole-6-carboxamide.png "Binimetinib Impurities")
![Binimetinib N-[2-(aminooxy)ethoxy]-impurity](https://structures.clearsynth.com/Binimetinib-N--2--aminooxy-ethoxy--impurity.png "Binimetinib Impurities")
